Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm, and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances.
You may also be interested in...
Cardio Conversations: iRhythm Prepares To Deliver ‘Standard-Of-Care’ Cardiac Monitoring
Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US.
Decentralized Clinical Trial Guidance Fulfills Promise, Underlies Digitization Of Healthcare
The FDA’s long-awaited guidance on decentralized clinical trials underscores the importance of digital health tech in clinical trials.
Using The Metaverse To Break Down Language Barriers and Improve Diversity In Clinical Trials
Wipro’s life science and medical device lead Gaurica Chacko’s told Medtech Insight about why diversity in healthcare matters to her and what her team is doing to increase it.